Q-omics provides the consensus-scored SNORD1A profile across patient tissues and cancer cell-line models. Additionally, SNORD1A RNA expression shows 1 significant drug associations, with the highest sampling consensus in PEMB_ALL.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for SNORD1A — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

Locus: 17q25.1 &middot; small nucleolar RNA, C/D box 1A
External: <a href="https://www.ncbi.nlm.nih.gov/gene/677848" target="_blank" rel="noopener" class="lin">NCBI Gene &middot; <a href="https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000278261" target="_blank" rel="noopener" class="lin">Ensembl

This table shows molecular features associated with SNORD1A in patient tissues and cancer cell lines. In patient samples, SNORD1A shows the broadest associations at the RNA and protein expression levels, with PEMB_ALL recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Drug	1	PEMB_ALL (1)	view →